CRYOPORT, INC. Investment Income, Net
CRYOPORT, INC. (CYRX) reported Investment Income, Net of $3.13 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-06
- CRYOPORT, INC. investment income, net for the quarter ending 2026-06-30 was $3.13M, a 113.64% increase year-over-year.
- CRYOPORT, INC. investment income, net for the quarter ending 2026-03-31 was $3.09M, a 96.44% increase year-over-year.
- CRYOPORT, INC. investment income, net for the quarter ending 2025-12-31 was $3.36M, a 135.25% increase year-over-year.
- CRYOPORT, INC. investment income, net for the quarter ending 2025-09-30 was $3.40M, a 11.21% increase year-over-year.
- CRYOPORT, INC. investment income, net for fiscal 2025 was $9.80M, a 0.98% decline from fiscal 2024.
- CRYOPORT, INC. investment income, net for fiscal 2024 was $9.89M, a 6.45% decline from fiscal 2023.
- CRYOPORT, INC. investment income, net for fiscal 2023 was $10.58M, a 24.82% increase from fiscal 2022.
- CRYOPORT, INC. investment income, net for fiscal 2022 was $8.47M, a 160.50% increase from fiscal 2021.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.13M 10-Q · filed 2026-08-06 | $6.22M 10-Q · filed 2026-08-06 | $9.58M derived: sum of 3 quarters · filed 2026-08-06 | $12.98M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.09M 10-Q · filed 2026-05-05 | $6.45M derived: sum of 2 quarters · filed 2026-05-05 | $9.85M derived: sum of 3 quarters · filed 2026-05-05 | $11.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $6.76M derived: sum of 2 quarters · filed 2026-03-05 | $8.22M derived: sum of 3 quarters · filed 2026-08-06 | $9.80M 10-K · filed 2026-03-05 |
| 2025-09-30 | $3.40M 10-Q · filed 2025-11-06 | $4.87M derived: sum of 2 quarters · filed 2026-08-06 | $6.44M 10-Q · filed 2025-11-06 | $7.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.47M 10-Q · filed 2026-08-06 | $3.04M 10-Q · filed 2026-08-06 | $4.47M derived: sum of 3 quarters · filed 2026-08-06 | $7.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.57M 10-Q · filed 2026-05-05 | $3.00M derived: sum of 2 quarters · filed 2026-05-05 | $6.06M derived: sum of 3 quarters · filed 2026-05-05 | $8.87M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $4.49M derived: sum of 2 quarters · filed 2026-03-05 | $7.29M derived: sum of 3 quarters · filed 2026-03-05 | $9.89M 10-K · filed 2026-03-05 |
| 2024-09-30 | $3.06M 10-Q · filed 2025-11-06 | $5.87M derived: sum of 2 quarters · filed 2025-11-06 | $8.47M 10-Q · filed 2025-11-06 | $11.08M derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | $2.81M 10-Q · filed 2025-08-12 | $5.41M 10-Q · filed 2025-08-12 | $8.02M derived: sum of 3 quarters · filed 2026-03-05 | $10.87M derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | $2.60M 10-Q · filed 2025-05-08 | $5.21M derived: sum of 2 quarters · filed 2026-03-05 | $8.06M derived: sum of 3 quarters · filed 2026-03-05 | $10.71M derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $5.46M derived: sum of 2 quarters · filed 2026-03-05 | $8.11M derived: sum of 3 quarters · filed 2026-03-05 | $10.58M 10-K · filed 2026-03-05 |
| 2023-09-30 | $2.85M 10-Q · filed 2024-11-07 | $5.50M derived: sum of 2 quarters · filed 2024-11-07 | $7.96M 10-Q · filed 2024-11-07 | $10.64M derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-06-30 | $2.65M 10-Q · filed 2024-08-08 | $5.11M 10-Q · filed 2024-08-08 | $7.79M derived: sum of 3 quarters · filed 2025-03-07 | $10.28M derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-03-31 | $2.47M 10-Q · filed 2024-05-08 | $5.14M derived: sum of 2 quarters · filed 2025-03-07 | $7.63M derived: sum of 3 quarters · filed 2025-03-07 | $9.68M derived: sum of 4 quarters · filed 2025-03-07 |
| 2022-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $5.16M derived: sum of 2 quarters · filed 2025-03-07 | $7.21M derived: sum of 3 quarters · filed 2025-03-07 | $8.47M 10-K · filed 2025-03-07 |
| 2022-09-30 | $2.48M 10-Q · filed 2023-11-09 | $4.53M derived: sum of 2 quarters · filed 2023-11-09 | $5.80M 10-Q · filed 2023-11-09 | $7.43M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | $2.05M 10-Q · filed 2023-08-09 | $3.31M 10-Q · filed 2023-08-09 | $4.95M derived: sum of 3 quarters · filed 2024-03-13 | $5.80M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | $1.26M 10-Q · filed 2023-05-04 | $2.90M derived: sum of 2 quarters · filed 2024-03-13 | $3.75M derived: sum of 3 quarters · filed 2024-03-13 | $4.12M derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $2.49M derived: sum of 2 quarters · filed 2024-03-13 | $2.85M derived: sum of 3 quarters · filed 2024-03-13 | $3.25M 10-K · filed 2024-03-13 |
| 2021-09-30 | $851.00K 10-Q · filed 2022-11-04 | $1.22M derived: sum of 2 quarters · filed 2022-11-04 | $1.62M 10-Q · filed 2022-11-04 | $1.57M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $368.00K 10-Q · filed 2022-08-04 | $766.00K 10-Q · filed 2022-08-04 | $719.00K derived: sum of 3 quarters · filed 2023-02-28 | $907.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $398.00K 10-Q · filed 2022-05-05 | $351.00K derived: sum of 2 quarters · filed 2023-02-28 | $539.00K derived: sum of 3 quarters · filed 2023-02-28 | $852.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $141.00K derived: sum of 2 quarters · filed 2023-02-28 | $454.00K derived: sum of 3 quarters · filed 2023-02-28 | $761.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $188.00K 10-Q · filed 2021-11-04 | $501.00K derived: sum of 2 quarters · filed 2021-11-04 | $808.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $313.00K 10-Q · filed 2021-08-06 | $620.00K 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $307.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $583.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |